IONS•benzinga•
HC Wainwright & Co. Initiates Coverage On Ionis Pharmaceuticals with Buy Rating, Announces Price Target of $45
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 7, 2025 by benzinga